Biofrontera quadruples shareholder base and increases trading volume
With the three capital increases that Biofrontera has, in spite of the difficult market conditions, been able to close this year, the company's share number increased to 7.6 mln. In parallel, the free-float grew to over 60%, such that the majority of the shares is now held by small funds and private investors.
"The significant expansion of the shareholder base and the increased liquidity of the stock reflect the positive development of Biofrontera's business. They serve as important benchmarks, which find strong attention when addressing investment groups," commented Werner Pehlemann, CFO of Biofrontera AG, the development.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.